Insider Title Company Date Price Return Shares Value
Duggan Robert W Non-Executive Director PULSE BIOSCIENCES, INC. (PLSE) 2024-12-13 $17.18 0.0% 55,256 $949,298
Duggan Robert W Non-Executive Director PULSE BIOSCIENCES, INC. (PLES) 2024-12-12 $17.13 0.0% 45,404 $777,771
Duggan Robert W Non-Executive Director Pulse Biosciences, Inc. (PLSE) 2023-12-12 $9.15 91.0% 17,999 $164,691
Duggan Robert W Non-Executive Director Pulse Biosciences, Inc. (PLSE) 2023-12-11 $9.36 86.8% 90,118 $843,504
Duggan Robert W Non-Executive Director Pulse Biosciences, Inc. (PLSE) 2023-12-08 $9.54 83.2% 116,656 $1,112,898
Duggan Robert W Non-Executive Director Pulse Biosciences, Inc. (PLSE) 2023-12-07 $9.19 90.2% 74,852 $687,890
Duggan Robert W Non-Executive Director Pulse Biosciences, Inc. (PLSE) 2023-12-06 $9.06 92.9% 82,813 $750,286
Duggan Robert W Non-Executive Director Pulse Biosciences, Inc. (PLSE) 2023-12-05 $9.34 87.2% 66,021 $616,636
Duggan Robert W Non-Executive Director Pulse Biosciences, Inc. (PLSE) 2023-12-04 $10.38 68.4% 27,000 $280,260
Duggan Robert W Non-Executive Director Pulse Biosciences, Inc. (PLSE) 2023-12-01 $9.07 92.7% 45,600 $413,592
Duggan Robert W Non-Executive Director Pulse Biosciences, Inc. (PLSE) 2023-11-30 $9.06 92.9% 152,944 $1,385,673
Duggan Robert W Non-Executive Director Pulse Biosciences, Inc. (PLSE) 2023-11-29 $9.38 86.4% 218,600 $2,049,784
Duggan Robert W Non-Executive Director Pulse Biosciences, Inc. (PLSE) 2023-11-28 $8.98 94.7% 124,397 $1,117,085
Duggan Robert W Non-Executive Director Pulse Biosciences, Inc. (PLSE) 2023-11-17 $6.10 186.6% 20,241 $123,470
Duggan Robert W Non-Executive Director Pulse Biosciences, Inc. (PLSE) 2023-05-09 $6.51 168.5% 10,022,937 $65,249,320
Duggan Robert W Chief Executive Officer Summit Therapeutics Inc. (SMMT) 2022-08-16 $0.97 1188.7% 94,849,203 $92,003,727
Duggan Robert W Non-Executive Director Pulse Biosciences, Inc. (PLSE) 2021-06-30 $16.40 6.6% 3,048,780 $49,999,992
Duggan Robert W Chief Executive Officer Summit Therapeutics Inc. (SMMT) 2021-05-12 $5.24 138.5% 11,365,921 $59,557,426
Duggan Robert W Chief Executive Officer Summit Therapeutics Inc. (SMMT) 2020-11-06 $3.34 274.3% 14,071,856 $46,999,999
Return Profit / (loss) Cost
Total 438.9% $1,426,855,603 $325,083,302